The pharmacokinetic and safety profiles of nasal salmon calcitonin in Japanese healthy male volunteers.

被引：0
|
作者：
Itabashi, A
Nagamatsu, S
Hasegawa, M
Tsuboi, M
Nakamichi, N
Kohno, T
机构：
[1] Saitama Med Sch, Moroyama, Saitama 35004, Japan
[2] Kyorin Univ, Sch Med, Mitaka, Tokyo 181, Japan
[3] NS Clin, Hachioji, Tokyo, Japan
[4] Jikei Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2000年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU418
引用
收藏
页码：S433 / S433
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers.
    Nomura, T
    Zhang, J
    Nakatsuka, A
    Nomoto, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 74P - 74P
  • [22] The effect of morphine in combination with ethanol on safety, pharmacodynamic (PD) and pharmacokinetic (PK) measures in healthy volunteers.
    Sokolowska, M.
    Sun, S.
    Johnson, F.
    Schuller, R.
    Stauffer, J.
    Romach, M.
    Sellers, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S67 - S67
  • [23] A pharmacokinetic trial of thymosin α1 (Tα1) in healthy volunteers.
    Merritt, G
    Tuthill, CW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 160 - 160
  • [24] ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.
    Seong, S.
    Kang, W.
    Ohk, B.
    Kim, B.
    Gwon, M. -R.
    Cho, S.
    Lee, H.
    Yoon, Y. -R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S70 - S70
  • [25] Lack of pharmacokinetic interaction between morphine and dextromethorphan in healthy volunteers.
    Caruso, FS
    Johnson, DA
    Noonan, PK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 122 - 122
  • [26] Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers
    Kinoshita, Shuji
    Kondo, Kazuoki
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (01) : 7 - 14
  • [27] Pharmacokinetic and pharmacodynamic profile of the CCKA antagonist tarazepide in healthy volunteers.
    de Vries, MH
    Van den Broeck, P
    UdodeHaes, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 122 - 122
  • [28] Pharmacokinetic/pharmacodynamic (PK/PD) modeling of captopril in healthy volunteers.
    Yi, SY
    Bae, KS
    Lim, HS
    Cho, JY
    Yu, KS
    Jang, IJ
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P74 - P74
  • [29] PHARMACOKINETICS AND TOLERABILITY OF ELETRIPTAN IN KOREAN HEALTHY MALE VOLUNTEERS.
    Shin, K. H.
    Cha, Y. J.
    Ahn, L.
    Lim, K. S.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S70 - S71
  • [30] Pharmacokinetics and safety of (S)-Oxybutynin in normal healthy volunteers.
    Koch, P
    McCullough, JR
    Blum, PS
    Degraw, S
    Krause, AC
    Rubin, PD
    FASEB JOURNAL, 1998, 12 (04): : A142 - A142
12345